Privia Health Group (NASDAQ:PRVA) CFO David Mountcastle Sells 5,361 Shares

Privia Health Group, Inc. (NASDAQ:PRVA) CFO David Mountcastle sold 5,361 shares of Privia Health Group stock in a transaction that occurred on Thursday, February 26th. The shares were sold at an average price of $25.00, for a total transaction of $134,025.00. Following the completion of the transaction, the chief financial officer directly owned 172,909 shares in the company, valued at approximately $4,322,725. This represents a 3.01% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

David Mountcastle also recently made the following trade(s):

• On Friday, February 27th, David Mountcastle sold 7,697 shares of Privia Health Group stock. The stock was sold at an average price of $25.05, for a total transaction of $192,809.85.
• On Friday, December 12th, David Mountcastle sold 23,887 shares of Privia Health Group stock. The shares were sold at an average price of $25.03, for a total transaction of $597,891.61.

Privia Health Group Trading Up 1.2%

PRVA traded up $0.29 during trading on Monday, hitting $24.04. The stock had a trading volume of 1,472,614 shares, compared to its average volume of 813,700. The firm has a market cap of $2.96 billion, a PE ratio of 141.41, a P/E/G ratio of 1.59 and a beta of 0.82. Privia Health Group, Inc. has a 12 month low of $18.77 and a 12 month high of $26.51. The company has a 50 day simple moving average of $23.07 and a 200-day simple moving average of $23.50.

Privia Health Group (NASDAQ:PRVA) last released its quarterly earnings results on Thursday, February 26th. The company reported $0.25 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.04 by $0.21. The company had revenue of $541.17 million during the quarter, compared to analysts’ expectations of $516.61 million. Privia Health Group had a net margin of 1.08% and a return on equity of 3.06%. The business’s quarterly revenue was up 17.4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.21 earnings per share. As a group, sell-side analysts anticipate that Privia Health Group, Inc. will post 0.14 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

PRVA has been the subject of several research reports. Barclays increased their price objective on Privia Health Group from $22.00 to $23.00 and gave the company an “equal weight” rating in a research report on Monday, November 10th. JPMorgan Chase & Co. increased their price target on shares of Privia Health Group from $32.00 to $33.00 and gave the company an “overweight” rating in a report on Thursday, November 13th. Stephens restated an “overweight” rating and issued a $32.00 price target on shares of Privia Health Group in a research report on Thursday, December 4th. Piper Sandler reaffirmed an “overweight” rating and set a $36.00 price objective on shares of Privia Health Group in a research report on Thursday. Finally, Citigroup reiterated a “market outperform” rating on shares of Privia Health Group in a research note on Tuesday, January 6th. Thirteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $30.93.

Institutional Investors Weigh In On Privia Health Group

Institutional investors and hedge funds have recently made changes to their positions in the company. Invesco Ltd. raised its stake in shares of Privia Health Group by 5.1% in the fourth quarter. Invesco Ltd. now owns 427,615 shares of the company’s stock valued at $10,139,000 after acquiring an additional 20,652 shares during the last quarter. Wellington Management Group LLP increased its holdings in Privia Health Group by 3.8% during the 4th quarter. Wellington Management Group LLP now owns 233,446 shares of the company’s stock valued at $5,535,000 after purchasing an additional 8,531 shares in the last quarter. Millennium Management LLC increased its holdings in Privia Health Group by 19.0% during the 4th quarter. Millennium Management LLC now owns 702,744 shares of the company’s stock valued at $16,662,000 after purchasing an additional 112,428 shares in the last quarter. Gotham Asset Management LLC raised its position in Privia Health Group by 22.4% in the 4th quarter. Gotham Asset Management LLC now owns 36,995 shares of the company’s stock valued at $877,000 after purchasing an additional 6,773 shares during the last quarter. Finally, Freestone Grove Partners LP boosted its stake in Privia Health Group by 40.6% in the fourth quarter. Freestone Grove Partners LP now owns 1,213,342 shares of the company’s stock worth $28,768,000 after purchasing an additional 350,194 shares in the last quarter. Institutional investors and hedge funds own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.